The slip
PARKINSON RECEIPTno. 11829
27 Oct 2026, 10:32 UTCdopamine neurons, braak
predictionUBIAD1 in dopamine neurons tracks Braak Lewy-body stage
registerede23670ae251a0bf5
discovery+0.08 p=0.842 n=9
replication-0.66 p=0.053 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.08, p 0.842)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT9c21362406670148c6cedc27…
follows 3a3980211b6b…
Covered by the on-chain checkpoint of receipt 11841 (2026-10-27 10:49 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 11829: UBIAD1 in dopamine neurons, braak
- power
- full sample -0.34 (p 0.167, n 18), 95% CI -0.70 to +0.15. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.26 (p 0.289, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.34 (p 0.173, n 18). could be the mix.
- skeptic
- leave-one-out range -0.44 to -0.26, sign flips 0; without severely affected donors -0.34 (p 0.167, n 18). fragile.
- cell type
- strongest in oligodendrocytes: -0.72 (p 7.0e-4, n 18) vs -0.34 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for UBIAD1 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up UBIAD1 · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.68 p 0.016 (needs p < 1.9e-4)